Institution: McGill University, Faculty of Medicine and Health Sciences
Location: Montréal, Quebec, Canada
Salary: Commensurate with qualifications and experience
Closing Date: July 4, 2025
McGill University’s Faculty of Medicine and Health Sciences invites applications for nomination to a Canada Excellence Research Chair (CERC) in RNA Neurotherapeutics. The CERC program supports Canadian universities in recruiting and retaining top-tier researchers, advancing Canada’s position as a global leader in research and innovation. These awards are among the most prestigious and well-funded globally, offering either CAD $4 million or $8 million over eight years.
The successful nominee will be an internationally recognized researcher—whether from academia or industry—specializing in RNA-based research related to neuropsychiatry. The Chairholder will develop a cutting-edge research program aimed at translating RNA technologies into therapeutic strategies for brain and neuropsychiatric disorders. The research should integrate multiple levels of inquiry (molecular, cellular, behavioral, clinical) and may leverage advanced computational approaches, including artificial intelligence and machine learning.
The Chair will be based at the Douglas Institute, a leading mental health research centre affiliated with McGill, renowned for its translational imaging platforms, functional genomics expertise, and the Douglas-Bell Canada Brain Bank.
This appointment builds on major institutional investments in RNA research, including McGill’s leadership of DNA to RNA (D2R), a Canada First Research Excellence Fund initiative. D2R fosters interdisciplinary collaboration aimed at advancing RNA therapeutics for conditions that are difficult to treat using traditional modalities.
Candidate Requirements
Applicants should meet the following criteria:
- Hold a Ph.D. or equivalent and have an established research program in RNA neurobiology or RNA-based therapeutic development.
- Demonstrate a record of impactful research, team leadership, and innovation in RNA tool and technology development.
- Be qualified for appointment at the rank of Full Professor, or be an Associate Professor expected to attain Full Professor status within one to two years.
- Present a strong publication record in leading peer-reviewed journals and a history of external research funding.
- Show evidence of collaborative leadership across disciplines and sectors.
- Demonstrate a commitment to teaching, graduate student supervision, and academic service.
- Be prepared to contribute meaningfully to McGill’s equity, diversity, and inclusion efforts, as outlined in the university’s institutional frameworks.
Equity and Inclusion
McGill University is committed to equity and diversity within its community. Applications from members of racialized groups, women, Indigenous persons, persons with disabilities, LGBTQ+ individuals, and other underrepresented groups are encouraged.
Accommodations are available throughout the application process. Candidates requiring accommodations may contact Heather Purdie in confidence at heather.purdie@mcgill.ca.
McGill values diverse research perspectives and encourages applicants to describe the broader impact of their work across disciplines, sectors, and communities. Consideration will also be given to career interruptions or delays due to family or health-related leave.
Application Instructions
Applications must be submitted through Workday: McGill Careers. Required documents:
- Cover letter
- Curriculum vitae
- Statement of research interests
- Names and contact information of three referees
Application deadline: July 4, 2025 (30 days from posting date, June 4, 2025).
